NDC 59627-003

Avonex Pen

Interferon Beta-1a

Avonex Pen is a Intramuscular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Biogen Inc.. The primary component is Interferon Beta-1a.

• Product ID: 59627-003_395d29d6-6e90-4545-8d3b-ba2b40f77ba1
• NDC: 59627-003
• Product Type: Human Prescription Drug
• Proprietary Name: Avonex Pen
• Generic Name: Interferon Beta-1a
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2003-05-23
• Marketing Category: BLA /
• Application Number: BLA103628
• Labeler Name: Biogen Inc.
• Substance Name: INTERFERON BETA-1A
• Active Ingredient Strength: 30 ug/.5mL
• Pharm Classes: Interferon beta [EPC], Interferon-beta [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 59627-003-01

1 SYRINGE in 1 CARTON (59627-003-01) > .5 mL in 1 SYRINGE

• Marketing Start Date: 2003-05-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 59627-003-04 [59627000304]

AVONEX PEN INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA103628
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-05-23
• Marketing End Date: 2016-06-30

NDC 59627-003-01 [59627000301]

AVONEX PEN INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA103628
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2003-05-23
• Marketing End Date: 2016-06-30

Drug Details

Medicade Reported Pricing

59627000304 AVONEX PEN 30 MCG/0.5 ML KIT

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Avonex Pen" or generic name "Interferon Beta-1a"

NDC	Brand Name	Generic Name
59627-002	Avonex	Interferon Beta-1a
44087-0022	REBIF	INTERFERON BETA-1A
44087-0044	REBIF	interferon beta-1a
44087-8822	Rebif	interferon beta-1a
44087-0188	REBIF REBIDOSE	INTERFERON BETA-1A
44087-3322	REBIF REBIDOSE	INTERFERON BETA-1A
44087-3344	REBIF REBIDOSE	INTERFERON BETA-1A